S N Masikhina

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The efficiency of rispolept was examined in open non-comparative study which included 32 patients 6.5-16 years of age with schizophrenic spectrum disorders. Efficiency of the drug was estimated by clinical psychopathologic method together with the evaluation according to the PANSS. 5 patients were additionally estimated according to the Children's(More)
Sixty inpatients, aged 7 to 15 years, with obsessive-compulsive disorders (OCD) have been examined. The inclusion criteria comprised diagnostic ICD-10 criteria for OCD (F42), schizophrenia childhood type (F20.83) and neurotic-like schizophrenia (F21.3). Patients with organic CNS disorder signs and marked somatic pathology were excluded from the study.(More)
  • 1